Yesterday’s Federal Court decision invalidating Pfizer’s Norvasc (amlodipine besylate) could give an early boost to Novartis’ Exforge. “Besides the generic companies that will be launching their ...

Nov. 11, 2005 — The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for ...

For both hypertension and angina the usual initial dose is 5 mg amlodipine once daily which may be increased to a maximum dose of 10 mg depending on the individual patient's response. In hypertensive ...

Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

Pfizer Wins Challenge to Norvasc Patent by Mylan Laboratories NEW YORK, Feb. 27 -- Pfizer Inc said today that a federal court in the Western District of Pennsylvania (Pittsburgh) has upheld the ...

Shares of US generic drugmaker Mylan Laboratories jumped 5.3% to $20.40 on October 4, overshooting the firm’s 52-week high on the news that final clearance from the US Food and Drug Administration to ...

New York, NY (Jan. 31)-Pfizer, Inc. scored a victory over Synthon IP in a patent infringement lawsuit over the manufacturing process for ?Norvasc? (amlodipine). According to Pfizer, the federal ...

A federal court jury in the Eastern District of Virginia ruled unanimously that Pfizer did not infringe Synthon IP’s US patent covering a process for making amlodipine, the active ingredient in the ...

The ‘Amlodipine Besylate Market study‘ 2020 offers an in-depth analysis pertaining to potential drivers fueling this industry. The study also elucidates valuable insights about profitability position, ...

The battle over generic rights to Pfizer's blockbuster blood pressure pill Norvasc slogs on, with a new chalk mark in favor of Mylan Laboratories. First, a short recap. Mylan has been selling copycat ...

Unichem laboratories Limited are pleased to announce that it has received ANDA approval from the United States Food and Drug Administration (US FDA) for Amlodipine Besylate Tablets. Amlodipine ...